SPCC shared on LinkedIn:
“Mark your calendars!
In this session we will discuss:
∙ Clarification of current treatment guidelines – perspectives of clinical implementation?
∙ Benefit/cost ratio of treatment escalation and diagnostic steps vs recurrence risk
With experts Michael Gnant (AT) and Stephen Johnston (UK), and discussant FIORITA POULAKAKI (GR).
27 November – 18:00 CET
Register now.
This webinar is supported by an unrestricted educational grant from Eli Lilly.”
